Refine by
Infusion Device Articles & Analysis
8 news found
The jointly developed therapy features a micro-infusion device that tightly controls drug delivery to a region of the brain for patients with medically refractory epilepsy. ...
“The study results also established the compatibility and utility of the continuous ambulatory infusion device with our proprietary subcutaneous formulation. Lenalidomide has been an effective immunomodulatory drug in hematologic malignancies for years, however adverse events, notably neutropenia, have limited its use in certain patient settings. ...
“Progressing to the final dosing interval marks a major milestone in our development program; this study has established the compatibility and utility of the continuous infusion device with our subcutaneous formulation. Lenalidomide has been an effective immunomodulatory drug in hematologic malignancies for years, however adverse events, notably ...
Following the announced closing of the acquisition of Ivenix and its advanced infusion pump technology, Fresenius Kabi now offers healthcare professionals a broad and expanding portfolio of advanced infusion pumps and solutions to meet health care needs across the continuum of care. ...
Such SG EZ-be Pod is a small, wearable infusion device that can be programmed for a wide range of medications and delivery profiles, including at-home delivery. This subcutaneous drug delivery system is the flagship for Bexson’s proprietary ketamine formulation, BB106, and leverages Stevanato Group’s existing technology and broad experience in medical ...
As Senior VP, Drug Delivery, Moberg will lead the development of Bexson's drug delivery technologies, starting with a wearable infusion device for its BB106 therapy, in partnership with Italian drug containment solution and medical device manufacturer, Stevanato Group. ...
The jointly developed therapy features a micro-infusion device which tightly controls drug delivery to a region of the brain for patients with medically refractory epilepsy. ...
Other product segments projected to see above average gains in demand include infusion and hypodermic devices, diagnostic and laboratory disposables, nonwoven garments and textiles, and respiratory supplies and devices. ...